https://www.selleckchem.com/products/ki20227.html
Background Arrhythmogenic cardiomyopathy (ACM) is a genetic disorder with an estimated prevalence between 12,000 and 15,000 and is characterized by the fibrofatty replacement of cardiomyocytes that predisposes to malignant arrhythmias, heart failure, and sudden cardiac death. The diagnosis is based on the 2010 Task Force Criteria including family history, electrocardiographic traits and arrhythmogenic pattern, specific gene mutations, and structural and/or histological abnormalities. Most ACMs display an autosomal dominant mode of inher
Like
Comment
Share
